Clinical trial design in contemporary device studies in heart failure: Is there a gold standard?

Journal of Cardiac Failure

Volumn 20, Issue 4, 2014, Pages 223-228

  Hauptman, Paul J ^a   Gottlieb, Stephen S ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trials; heart failure; implantable devices

Indexed keywords

PLACEBO;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR THERAPEUTIC DEVICE; CLINICAL EFFECTIVENESS; CROSSOVER PROCEDURE; DEVICE APPROVAL; DEVICE SAFETY; DOUBLE BLIND PROCEDURE; DOUBLE CROSSOVER PROCEDURE; EXPERIMENTAL THERAPY; FAINTNESS; GOLD STANDARD; HEART FAILURE; HUMAN; IMPLANT; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; NONIMPLANTABLE CARDIOVASCULAR THERAPEUTIC DEVICE; OPEN STUDY; PARALLEL DESIGN; PRIORITY JOURNAL; PROTECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE BLIND PROCEDURE; SINGLE CROSSOVER PROCEDURE; STANDARD; STUDY DESIGN; VAGUS NERVE STIMULATION; CLINICAL TRIAL (TOPIC); HEART ASSIST DEVICE; STANDARDS;

CLINICAL TRIALS AS TOPIC; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS;

EID: 84897467828     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2014.01.009     Document Type: Article

References (15)

1. T.P. Archer, and C.V. Leier Placebo treatment in congestive heart failure Cardiology 81 1992 125 133 (Pubitemid 23052123)
2. R.F. Grenfell, A.H. Briggs, and W.C. Holland A double-blind study of the treatment of hypertension JAMA 176 1961 124 128
3. A.J.M. de Craen, P.J. Roos, A.L. de Vries, and J. Kleijnen Effect of colour of drugs: systematic review of perceived effect of drugs and their effectiveness BMJ 313 1996 1624
4. S. Cazeau, C. Leclercq, T. Lavergne, S. Walker, C. Varma, and S. Garrigue et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay N Engl J Med 344 2001 873 880 (Pubitemid 32224395)
5. J.D. Bisognano, G. Bakris, and M.K. Nadim Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled Rheos Pivotal Trial J Am Coll Cardiol 58 2011 765 773
6. S.L. Higgins, J.D. Hummel, I.K. Niazi, M.C. Giudici, S.J. Worley, and L.A. Saxon et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias J Am Coll Cardiol 42 2003 1454 1459 (Pubitemid 37267289)
7. S.J. Connolly, R. Sheldon, K.E. Thorpe, R.R. Roberts, K.A. Ellenbogen, and B.L. Wilkoff et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: VPS II JAMA 289 2003 2224 2229
8. FDA Executive Summary. Circulatory System Devices Panel Meeting, December 7, 2011. http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/ CirculatorySystemDevicesPanel/UCM282274.pdf. Accessed February 10, 2014.
9. C. Linde, M. Gold, W.T. Abraham, and J.C. Daubert Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure - the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study Am Heart J 151 2006 288 294 (Pubitemid 43144728)
10. A.B. Curtis, S.J. Worley, P.B. Adamson, E.S. Chung, I. Niazi, and L. Serfesee et al. Biventricular pacing for atrioventricular block and systolic dysfunction N Eng J Med 368 2013 1585 1593
11. D.L. Sackett Measuring the success of blinding in RCTs: don't, must, can not or needn't? Int J Epidemiol 36 2007 664 665
12. R.P. Byington, J.D. Curb, and M.E. Mattson Beta-Blocker Heart Attack Trial Research Group. Assessment of double-blindedness at the conclusion of the Beta-Blocker Heart Attack Trial JAMA 253 1985 1733 1736 (Pubitemid 15136535)
13. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health. Draft Guidance for Industry, Clinical Investigators, and Food and Drug Administration Staff: Design Considerations for Pivotal Clinical Investigations for Medical Devices. http://www.elsevierbi.com/∼/media/72C4230A20A746AF864EAAAFDCF0D4C2 (page 27). Accessed October 2, 2013.
14. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health. Guidance for Industry and FDA Staff - Clinical Investigations of Devices Indicated for the Treatment of Urinary Incontinence. http://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/ucm070852.htm#5d (section 5D). Accessed October 2, 2013.
15. E.A. Rose, A.C. Gelijns, A.J. Moskowitz, D.F. Heitjan, L.W. Stevenson, and W. Dembitsky et al. Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443